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A B S T R A C T
Selenium (Se) is a well-known anti-oxidant with a critical role in the proper functioning of nervous and
muscle functions. Se deﬁciency has been associated with both cognitive and neuromotor impairment,
while sensory and motor deﬁcits have been attributed to excess Se. In the Lower Tapajo´s Region of the
Brazilian Amazon, riverside populations present a wide range of Se levels. These ﬁsh-eating communities
have among the highest mercury (Hg) exposures reported in the world today, and recently, lead (Pb)
exposure has been identiﬁed. Some studies suggest that Se intake can be protective for Hg and/or Pb
toxicity, however, data from animal and human studies are inconsistent. The objective of the present
study was to examine the relations between biomarkers of Se and motor functions, taking into account
co-variables and biomarkers of exposure to Hg and Pb.
Participants (n = 448), aged 15–87y, were recruited from 12 communities along the Tapajo´s River. Se
concentrations were measured in whole blood (B-Se), plasma (P-Se), hair (H-Se) and urine (U-Se) by ICP-
MS. Whole blood Hg (B-Hg) and Pb (B-Pb) were also measured by ICP-MS. Interview-administered
questionnaires served to collect information on socio-demographics and medical history. All
participants underwent a complete visual examination and performed tests of motor functions
(Branches Alternate Movement Task, Santa Ana Test, Dynamometer and Grooved Pegboard Test).
B-Se varied from 103 to 1500 mg/L (median 228 mg/L), P-Se from 53.6 to 913 mg/L (median 135 mg/L),
H-Se from 0.4 to 3.8 mg/g (median 0.7 mg/g) and U-Se from 2.3 to 1375 mg/g cr. (median 33.6 mg/g cr.).
Median B-Hg and B-Pb levels were 42.5 mg/L and 113 mg/L respectively. In multivariable analysis, Se
biomarkers (log-transformed) were positively related to better performance on all motor tests, taking
into account socio-demographic co-variables and B-Hg and B-Pb levels. P-Se consistently showed
stronger associations to motor performance compared to the other Se biomarkers. Regression estimates
for Se biomarkers were considerably stronger when controlling for B-Hg. When stratifying at the median
for B-Hg concentrations, P-Se consistently presented associations with the outcomes only at high B-Hg
concentrations.
This is the ﬁrst human study to report beneﬁcial effects of high Se status on motor functions. For this
population with elevated Hg exposure, high dietary Se intake may be critical for brain and muscle
functions. However, these ﬁndings are not necessarily applicable to populations with lower Hg exposure
and/or Se status, which is the case for people who do not rely heavily on ﬁsh consumption, be they in
Brazil, the United States or elsewhere. The associations were mostly observed with P-Se, suggesting that
P-Se or plasma selenoproteins may be good biomarkers for these outcomes.
 2011 Elsevier Inc. 
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Selenium (Se) is an essential element and more than 25
different selenoproteins have been identiﬁed in humans. Although
the function of many selenoproteins has yet to be determined,
several are involved in antioxidant defense, thyroid homeostasis
and regulation of redox status (Reeves and Hoffmann, 2009). In the
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protective agent for neurons and myocytes through selenoprotein
expression in the brain, as well as in skeletal and cardiac muscles
(Chen and Berry, 2003; Lescure et al., 2009; Rayman et al., 2008;
Schweizer et al., 2004; Whanger, 2001).
Both Se deﬁciency and excess can lead to severe disorders. Low
Se status in the elderly has been associated with reduced
coordination, motor speed and muscle strength, and accelerated
cognitive decline (Akbaraly et al., 2007; Beck et al., 2007; Berr,
2000; Gao et al., 2007; Lauretani et al., 2007; Shahar et al., 2010).
Conversely, in Chinese populations, sensory and motor loss were
important characteristics in severe cases of selenosis (Yang et al.,
1983).
Experimental models have shown that trauma and other
neurodegenerative conditions, such as heavy metal exposures, can
exacerbate neuronal loss and dysfunctions induced by insufﬁcient
brain Se supply (Chen and Berry, 2003; Schweizer et al., 2004).
Conversely, some animal studies suggest that high Se intake may
alleviate mercury (Hg) and/or lead (Pb) toxicity (Ahamed et al.,
2007; Khan and Wang, 2009), but these effects are not consistently
observed, may differ throughout the lifespan or with respect to
measured outcomes (Newland et al., 2008). Epidemiological data
on the effects of Se in human populations exposed to Hg and/or Pb
are likewise inconsistent (Boucher et al., 2010; Choi et al., 2008a;
Despre´s et al., 2005; Saint-Amour et al., 2006; Steuerwald et al.,
2000).
In riverside communities of the Brazilian Amazon, there is a
wide range of Se status (Lemire et al., 2006, 2009, 2010a,b; Pinheiro
et al., 2005; Soares de Campos et al., 2002), reﬂecting intake from
local dietary Se sources, such as Brazil nuts, chicken, game meat,
ﬁsh, eggs and beef (Lemire et al., 2010a). These communities,
whose dietary mainstay is ﬁsh, also have among the highest
reported Hg exposure in the world today (Passos and Mergler,
2008). In the Lower Tapajo´s region, Hg dose-related visual and
motor decline have been reported (Dolbec et al., 2000; Lebel et al.,
1996, 1998). Recent ﬁndings have also revealed elevated lead (Pb)
exposure (Barbosa et al., 2009) in this region, but, to date, there are
no reports on the health consequences.
Plasma Se levels tend to saturate at high Se intake (Hansen et al.,
2004; Yang et al., 1989). Consequently, most studies on health
outcomes of persons with elevated Se status have used whole
blood and little information is available on other Se biomarkers. In
a recent study on age-related cataracts, we showed an inverse
association with plasma Se, but not whole blood (Lemire et al.,
2010b). The objective of the present study is to examine the
relations between Se concentrations in whole blood, plasma, urine
and hair and motor functions in riverside population of the Lower
Tapajo´s region, taking into account co-variables and environmen-
tal exposures to Hg and Pb.
2. Methods
2.1. Study population
This cross-sectional study is part of a larger interdisciplinary
project on factors that affect human Hg exposure and its health
effects (CARUSO, 2010). In the Lower Tapajo´s River Basin (State of
Para´, Brazil), there are approximately 50 communities of diverse
sizes and origins, with varying access to health care, education and
consumer goods. For this study, we selected 12 communities
(Fig. 1) to reﬂect the diversity of regional populations, social
conditions and ecosystems. We examined a large number of
outcomes (visual functions, motor performance, and cardiovascu-
lar responses) and sample-size calculation, based on visual
outcome measurements from preliminary studies, indicated thatwe would require a minimum of 400 people to test combined
effects of Hg and Se on this outcome.
Since it is difﬁcult to apply a random sampling strategy in this
setting (Passos et al., 2007), recruitment was based on a
convenience sampling procedure. Several weeks before the present
study, each village was visited and the study was explained at
village meetings and home visits. Persons 15 years and older were
invited to participate on a voluntary basis. The study protocol was
approved by the Ethics Review Boards of the University of Quebec
at Montreal and the Faculty of Pharmaceutical Sciences of the
University of Sa˜o Paulo-Ribeira˜o Preto. All participants signed an
informed consent form, which was read to them. There was no
remuneration for study participation.
Participation was limited to a maximum of 12 persons per day
because the examination procedure required bringing participants
by boat to a technical school in a nearby city, Itaituba, where we
had access to electricity and freezers for storing biological material.
Each village was scheduled for a speciﬁc number of days. The boats
arrived the previous evening and made the trip during the night.
The study was carried out in two periods from May to July 2006
(May 12 to June 3, and July 5 to July 29).
A total of 448 persons (216 men and 232 women) agreed to
participate. Reasons for non-participation included work and/or
domestic responsibilities, religious convictions, illnesses and lack
of interest in the study. We compared participants’ age distribution
to the underlying population based on a house-to-house survey
carried out in 2003. The participants in the present study represent
25% of the adult population of these villages (27% of all women and
23% of all men). The proportion of persons from each village varied
from 10% to 67%, with higher relative frequencies from the smaller
villages (the smallest consisted of 13 adult residents and the
largest, 384 adults). Younger persons (15y and <40y) were
underrepresented with respect to the age distribution of the entire
population (50% vs. 62%), those between 40y and 65y were
overrepresented (40% vs. 28%), while the oldest group (65y) was
similar to the underlying population (10%).
2.2. Socio-demographic characteristics
All participants answered an interview-administered question-
naire of approximately one hour on socio-demographic informa-
tion, occupational and residential history. A nurse administered a
further questionnaire on medical history. Research assistants
visited each participant in their homes and noted the names of all
currently used medication. Since agricultural practices are
different between those who live on the banks of the Tapajo´s
and those who reside on its tributaries, we classiﬁed the villages
with respect to their geographic location: seven villages were on
the Tapajo´s (Sa˜o Luis do Tapajo´s, Nova Cana˜a, Ipaupixuna, Brası´lia
Legal, Vista Alegre, Mussum, Santa Cruz) and ﬁve on the tributaries
(Santo Antoˆnio, Novo Paraı´so, Timbo´, Tec¸a, Ac¸aı´tuba).
2.3. Biomarkers’ assessment
2.3.1. Blood
For each participant, an experienced Brazilian phlebotomist
collected a 6 mL blood sample in ‘‘trace metals free’’ evacuated
tubes (BD Vacutainer1), containing heparin as anticoagulant. For
plasma separation, blood samples were centrifuged (800  g for
6 min). Plasma fractions were then pipetted into previously
cleaned Eppendorf1 tubes (2 mL), and immediately frozen at
20 8C. Blood total Hg (B-Hg), blood Se (B-Se) and blood lead (B-
Pb), as well as plasma total Hg (P-Hg) and plasma Se (P-Se) were
determined by inductively coupled plasma mass spectrometry
(ICP-MS, Perkin Elmer DRC II) according to the method proposed by
Batista et al. (2009), at the Laborato´rio de Toxicologia e Essencia-
M. Lemire et al. / NeuroToxicology 32 (2011) 944–953946lidade de Metais, Universidade de Sa˜o Paulo, Ribeira˜o Preto, SP,
Brazil. Quality control was guaranteed by analyzing two secondary
reference materials, provided by the external quality assessment
scheme (EQAS) for trace elements operated by the Institut National
de Sante´ Publique du Que´bec, Canada (QMEQAS 07B03 and QMEQAS
07B06; target values for Se = 228  28 and 459  43 mg/L, respec-
tively). Reference materials were analyzed before and after ten
ordinary samples. Measured values for reference samples were
uniformly within the range of reference values (Mean found values
for Se = 225  3 and 453  5 mg/L for QMEQAS 07B03 and QMEQAS
07B06, respectively).
2.3.2. Hair
Hair has often been used as a biomarker for current and
retrospective exposure to Se (Lemire et al., 2009). Hair strands
from the occipital region were cut next to the scalp with
stainless steel scissors and then placed in plastic bags, with the
root end stapled. The ﬁrst 2 cm were used to determine total
hair Se concentration (H-Se) by inductively coupled plasma
mass spectrometry (ICP-MS, Perkin Elmer DRC II) according to
the method proposed by Rodrigues et al. (2008), at the
Laborato´rio de Toxicologia e Essencialidade de Metais, Universidade
de Sa˜o Paulo, Ribeira˜o Preto, SP, Brazil. Quality control was
guaranteed by analyzing the Standard Reference Material
(Human Hair 086; acceptable range for Se: 0.80–1.20 mg/g),
provided by the International Atomic Energy Agency (IAEA).
Reference material was analyzed before and after ten ordinary
samples. Measured values for reference samples were uniformly
within the range of certiﬁed values (Mean found values:
1.02  0.09 mg/g Se).
2.3.3. Urine
A spot urine sample was collected in sterile metal-free plastic
containers, and then kept frozen at 20 8C until analysis. Urinary
total Se (U-Se) was determined by ICP-MS (Perkin Elmer ELAN DRC
II) according to the biomonitoring method proposed by Heitland
and Koster (2006), at the Laborato´rio de Toxicologia e Essencialidade
de Metais, Universidade de Sa˜o Paulo, Ribeira˜o Preto, SP, Brazil.
Quality control was veriﬁed by analyzing the Standard Reference
Material (NIST 2670a Toxic Metals in Urine; certiﬁed value for Se:
229.5  8.3 mg/L), provided by the National Institute of Standards
and Technology (NIST), USA. The Urine Reference Material was
analyzed every ten ordinary samples. Measured values for reference
sample was uniformly within the range of the certiﬁed values (mean
found value: 223  5 mg/L Se). Creatinine was determined in urine
by spectrophotometric ﬂow-injection analysis using the Jaffe
reaction in accordance with the method proposed by Sakai et al.
(1995). The World Health Organization (WHO) recommends that if a
sample is too diluted (creatinine concentration < 30 mg/dL) or too
concentrated (creatinine concentration > 300 mg/dL), the urine
sample should be excluded (WHO, 1996). For correction purposes,
U-Se levels were divided by the creatinine individual value and
expressed as mg/g cr.
2.3.4. Guidelines for Se status
Se deﬁciency has been set at P-Se < 70 mg/L, the concentration
at which the synthesis of some selenoproteins may be altered
when Se supply begins to be limiting (U.S. Institute of Medicine,
2000). The Tolerable Upper Intake level (UL) is currently 500 mg/
day (U.S. Institute of Medicine, 2000), corresponding to 560 mg/L in
whole blood (Yang and Xia, 1995). The No Observable Adverse
Effect Level (NOAEL) has been set at 1000 mg/L of B-Se (Poirier,
1996). The reported normal range for H-Se is between 0.1 and
5.0 mg/g (WHO, 1994). For urine, the absence of symptoms of
toxicity is usually associated with U-Se < 100 mg/L, while > 400–
700 mg/L are considered excessive (WHO, 2001).2.4. Ocular health and near visual acuity assessment
Ocular examinations were carried out by clinical optometrists
from the School of Optometry of the University of Montreal. The
anterior segment of the eye was examined using slit-lamp
biomicroscopy. The posterior segment of the retina and its
periphery were examined during pupillary dilation using two
mydriatic agents (tropicamide 1% and phenylephrine 2.5%) with
Volk lenses, through binocular indirect and direct ophthalmosco-
py. Iridocorneal angles were noted and intra-ocular pressure was
measured with a Perkins tonometer under topical anaesthesia. The
eye examination served to identify ocular pathologies and trauma
for post hoc exclusion. Near visual acuity at 40 cm was assessed
using the Allen Chart and far visual acuity at 6 m was assessed
using the Tumbling E chart. For the purpose of statistical analysis,
near visual acuity and far visual acuity were log transformed to
obtain the minimum angle of resolution (log MAR).
The four optometrists were trained prior to the ﬁeld study to
minimize inter-observer bias and were blinded to participants’
Se, Hg and Pb levels. A team of two optometrists performed
examinations from May 12 to June 3 and a second team of two,
from July 5 to 29. All examinations were made in the same room
and under the same conditions. For each team, in cases of doubt
in diagnosis, they consulted each other and arrived at a
consensus.
2.5. Motor functions assessment
The tests of motor functions (Branches Alternate Movement
Task (BAMT), Santa Ana Test (Helsinki Version), Grooved Pegboard
and Dynamometer) were administered by trained Brazilian
students, who did not know the participants’ Se, Hg and Pb levels.
The BAMT was administered by the same person throughout the
study. For the other three tests, one person administered them in
the ﬁrst testing period and another person in the second testing
period. In both periods, the tests were carried out in the same order
for each participant. The dominant hand was designated as that
with which the person used to hammer, to ﬁsh and/or to pick up
small items.
2.5.1. Branches Alternate Movement Task (BAMT)
This test, developed by Dr. Fernando Branches to assess motor
coordination in Hg-exposed patients (Lebel et al., 1998) is
illustrated in Fig. 2. After receiving an explanation of how to
perform the test, participants had the opportunity to practice the
movement before being tested. The number of repetitions in a 30
second trial was registered. The test was given to 420 of the 448
participants due to administrator absence for illness.
2.5.2. Santa Ana manual dexterity test
The Santa Ana test (Helsinki version) was used to determine
manual dexterity (Ha¨nninen and Lindstrom, 1979). The task
consists of lifting up square pegs with circular tops, turning them
180 degrees and replacing them in their holes as rapidly as
possible. Following a training period, participants performed two
trials of 30 s for each hand. The number of pegs successively turned
was recorded. The number of pegs successfully turned for the two
trials were averaged for the dominant and non dominant hand.
2.5.3. Dynamometer test
Maximum grip strength was assessed for both hands with a
hand-held dynamometer (Lafayette Instruments, model 78010)
over two trials. Mean values for the two trials were calculated for
each hand. Participants were encouraged to force as much as
possible to maintain their maximum grip strength; performance
was recorded in kg.
Fig. 1. Study area.
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The Grooved Pegboard test (Lafayette Instruments, model
32025) was used to assess manual dexterity and ﬁne eye-hand
movement. The participant was asked to place 25 pins into holes,
as quickly as possible. The pins were key-shaped and had to be
rotated to ﬁt into the holes. The test was performed ﬁrst with the
dominant hand and then with the non dominant hand for 2 trials.
The time required by the participant to complete this test was
recorded. Mean time for the two trials constituted the score for
each hand. If the participant did not complete the test within
5 min, the scores were not considered for the present analyses.
Since the test requires ﬁne eye-hand coordination, persons withFig. 2. The Branches Alternate Movement Task (BAMT) (Figure from Lebel et al., 1998). Su
with the right hand (2), followed by the crossing over of the left hand to touch the right k
arm to reach the left knee again (5). This sequence of movements 2–5 is repeated altenear visual acuity greater or equal to 20/40 for at least one eye
were excluded from analyses, as were participants diagnosed with
ophthalmic abnormalities and visual diseases that affect the
macula.
2.6. Statistical analyses
Descriptive analyses were performed to characterize the
population, biomarkers of Se, Hg and Pb and performances on
each test. One-way ANOVA (F ratio) were used to test the
difference of age distribution between genders. Non-parametric
Wilcoxon/Kruskal–Wallis tests (x2), non-parametric correlationalbjects keep initially both hands in upright position (1), and then touch the left knee
nee (3). Right hand is then retrieved from the left knee (4) and crossed over the left
rnatively as quickly as possible for a time period of 30 s.
Table 1
Characteristics of the study participants and neurofunctional test parameters.
N Mean (95% CI) Median Range
Age, y 407 41.5 (39.1–43.1) 40 15–87
Gender, N (%)
Women 204 (50.1)
Men 203 (49.9)
Village location, N (%)
Tapajo´s Rivera 271 (66.6)
Tributariesb 136 (33.4)
B-Se, mg/L 407 288 (269–306) 228 103–1500
P-Se, mg/L 407 163 (153–173) 135 54–913
H-Se, mg/g 393 0.84 (0.79–0.89) 0.69 0.38–3.81
U-Se, mg/g cr. 319 57.0 (45.7–68.3) 33.6 2.3–1375
B-Hg, mg/L 407 51.0 (47.5–54.6) 42.5 1.7–289
B-Pb, mg/L 407 133 (124–141) 113 5.9–483
BAMT, no. of repetitions 320c 58.7 (57.4–60.0) 60 20–90
Santa Ana, no. of pegs
Dominant hand 399c 18.0 (17.6–18.4) 18.5 3.5–27.0
Non dominant hand 396c 17.9 (17.5–18.3) 18.5 7.5–28.0
Dynamometer, kg
Dominant hand 396c 28.8 (28.1–29.6) 27.5 7.5–51.5
Non dominant hand 398c 28.3 (27.5–29.1) 26.8 6.0–53.5
Grooved pegboard, sec
Dominant hand 174c 58.7 (57.6–60.0) 58.5 41.5–84.5
Non dominant hand 176c 63.1 (61.8–64.4) 62.0 47.0–94.5
Education, y 405 4.9 (4.5–5.2) 4 0–16
Alcohol consumption,
N (%)
406
Drinkers 221 (54.4)
Nondrinkers 185 (45.6)
Smoking habit, N (%) 407
Current smoker 107 (26.3)
Non- or ex-smoker 300 (73.7)
a Sa˜o Luis do Tapajo´s, Nova Cana˜a, Ipaupixuna, Brası´lia Legal, Vista Alegre,
Mussum, Santa Cruz.
b Santo Antoˆnio, Novo Paraı´so, Timbo´, Tec¸a, Ac¸aı´tuba.
c Number of persons after exclusions for speciﬁc criterias of each test and
studentized residuals outliers (> 3 or < 3) in multiple regression models involving
B-Se or P-Se biomarkers.
Table 2
Spearman’s r correlation between Se, Hg and Pb biomarkers.
B-Se P-Se H-Se U-Se B-Hg
B-Se
P-Se 0.76***
H-Se 0.77*** 0.70***
U-Se 0.44*** 0.34*** 0.45***
B-Hg 0.19*** 0.22*** 0.09y 0.14**
B-Pb 0.13** 0.11* ns ns 0.40***
* P < 0.05.
** P < 0.01.
*** P < 0.0001
y P < 0.10.
ns, non-signiﬁcant.
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x2) were used to evaluate the associations between continuous
(e.g. biomarker levels) and binary variables (e.g. socio-demograph-
ic variables) when some variables did not display a normal
distribution.
Biomarker variables were log-transformed (log10) for paramet-
ric analyses. Pearson’s correlations and simple regression models
were used to evaluate the relationship between neurofunctional
test performances and biomarkers of Se status. In addition,
multiple linear regressions were used to evaluate the relationship
between biomarkers of Se and neurofunctional test performances,
taking into account relevant co-variables. Age, sex, smoking status
(yes vs. no), alcohol consumption (yes vs. no), years of formal
education (< 4y vs.  4y), and village location (Tapajo´s vs.
tributaries) were included in the ﬁrst model (Model 1). For the
tests that were administered by two different persons, ‘tester’ was
also included as a co-variable. In Model 2, we also included B-Hg
levels, while in the Model 3, we included B-Pb levels. Model 4
included all the co-variables of Model 1 and both B-Hg and B-Pb
levels. The relations between neurofunctional test performances
and the interactions term between Se biomarker variables and B-
Hg or B-Pb variables were likewise tested. Studentized residuals
greater than 3 and lower than 3 were considered as outliers and
excluded from the analysis. Results were deﬁned as statistically
signiﬁcant at P < 0.05. Analyses were performed using JMP 8.0
software (SAS Institute Inc.).
3. Results
The general exclusions for this study were pregnant and
breastfeeding women (N = 15), reported stroke (N = 14), taking
psychotropic medication (N = 7) and missing data for blood or
plasma biomarker (N = 5). A total of 407 participants, 204 women
and 203 men, were included in the present analyses. For urine
measurements, 76 participants were excluded because creatinine
concentrations were too diluted or too concentrated.
Mean age of the participants was 41.5 years old and no
difference in age distribution was observed between women and
men (40.3y [95% CI: 38.1–42.6] and 42.6y [95% CI: 40.4–44.9]
respectively; F ratio = 2.0, P = 0.16) (Table 1). Few participants
(11.8%) had completed elementary school (8 years) and fewer still
(2.5%) had ﬁnished high school (11 years), while 7.9% reported no
formal education.
In this population, most (94.3%) presented B-Se levels in the
normal range, however, 13 participants (3.2%) had B-Se levels
between 560 and 1000 mg/L, and 10 individuals (2.5%) had B-Se
levels over 1000 mg/L. Very few (N = 6) had deﬁcient P-Se levels,
and their P-Se levels varied between 53.6 and 70.0 mg/L. All
participants had H-Se levels between 0.1 and 5.0 mg/g and 291
participants (71.0%) had U-Se levels below 100 mg/g cr., while 30
participants (7.3%) had U-Se over 400 mg/g cr.
Biomarkers of Se did not vary between men and women,
smoking habits and the years of education. B-Se and H-Se levels
decreased with age (Spearman’s r = 0.11, P = 0.03 and r = 0.13,
P = 0.008 respectively), although this was not the case for P-Se and
U-Se levels (r = 0.07, P = 0.18 and r = 0.06, P = 0.20 respective-
ly). Se levels were also higher for alcohol consumers: B-Se
(Wilcoxon x2 = 4.0, P = 0.05), P-Se (x2 = 8.3, P = 0.004), H-Se
(x2 = 6.3, P = 0.01), except for U-Se (x2 = 1.4, P = 0.23).
Comparison of persons living on the Tapajo´s River to those on
the tributaries showed similar distributions for gender, age,
educational level and drinking habits, while those on the
tributaries had a higher percentage of smokers (35.3% vs. 21.8%;
Likelihood Ratio x2 = 8.3, P = 0.004). The proportion of persons who
reported carrying out subsistence agriculture was signiﬁcantly
higher in the villages located on tributaries (70.0% vs. 55.7%,x2 = 7.7, P = 0.006), while the proportion of those involved in
commercial ﬁshing and commercial trade was signiﬁcantly higher
in the villages located directly on the Tapajo´s River (15.0% vs. 3.7%,
x2 = 13.5, P = 0.0002 and 6.3%, vs. 0.7%, x2 = 8.6, P = 0.003,
respectively). Proportions were similar for those reporting
subsistence ﬁshing activities (68.9%), hunting (29.0%) and cattle
raising (36.5%). B-Hg concentrations were similar in the two
groups, but B-Pb and biomarkers of Se status were higher in
persons on the tributaries: median concentrations: B-Pb: 140 vs.
100 mg/L; P-Se: 144 vs. 131 mg/L; B-Se: 283 vs. 214 mg/L; H-Se:
0.82 vs. 0.66 mg/g; U-Se: 43.3 vs 30.1 mg/g cr (Wilcoxon x2,
P < 0.05).
B-Se, P-Se and H-Se levels were highly correlated (Table 2). U-Se
levels and other Se biomarkers were also correlated, but to a lesser
extent. B-Hg and B-Pb levels were positively correlated, and both
Table 3 (Continued )
Outcomes Log-Se biomarkers, mg/L
B-Se P-Se H-Se U-Se
Santa Ana, non dominant hand, number
r Pearson 0.09y 0.06 0.06 0.10y
b crude 1.6 1.2 1.2 1.0
(95% CI) (0.2/3.5) (0.7/3.2) (1.0/3.5) (0.1/2.1)
Model 1 b 0.9 0.5 0.1 0.3
(95% CI) (0.8/2.7) (1.2/2.3) (1.9/2.2) (0.8/1.4)
Model 2 b 1.3 0.8 0.4 0.3
(95% CI) (0.5/3.1) (1.0/2.6) (1.7/1.4) (0.8/1.3)
Model 3 b 1.2 0.7 0.3 0.3
(95% CI) (0.6/2.9 (1.1/2.5) (1.8/2.3) (0.8/1.4)
Model 4 b 1.4 0.8 0.4 0.3
(95% CI) (0.4/3.2) (0.9/2.7) (1.5/2.5) (0.8/1.4)
Dynamometer, dominant hand, kg
r Pearson 0.10y 0.10* 0.07 0.12*
b crude 3.7y 4.1* 3.3 2.7*
(95% CI) (0.1/7.5) (0.18.1) (1.3/7.8) (0.3/5.1)
Model 1 b 2.3 2.6 2.2 1.7
(95% CI) (0.8/5.4) (0.6/5.8) (1.6/5.9) (0.3/3.7)
R2 0.46 0.46
Model 2 b 3.2y 3.5* 2.8 1.6
(95% CI) (0.3/6.4) (0.2/6.8) (1.0/6.6) (0.4/3.6)
R2 0.47 0.47
Model 3 b 2.1 2.4 1.9 1.6
(95% CI) (1.0/5.3) (0.8/5.7) (1.8/5.7) (0.4/3.6)
R2 0.46 0.47
Model 4 b 3.0y 3.3* 2.7 1.5
(95% CI) (0.2/6.3) (0.5/6.6) (1.1/6.5) (0.5/3.5)
R2 0.47 0.47
Dynamometer, non dominant hand, kg
r Pearson 0.07 0.07 0.06 0.09
b crude 3.2 3.7y 2.0 3.4**
(95% CI) (0.9/7.3) (0.6/8.0) (2.8/6.9) (1.0/5.9)
Model 1 b 2.0 1.7 0.3 0.1
(95% CI) (1.2/5.1) (1.5/4.9) (4.2/4.9) (2.3/0.6)
Model 2 b 2.7 2.4 1.2 0.2
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Hg levels were negatively correlated to U-Se levels.
The number of participants who completed or were considered
admissible were different for each neurofunctional test. For the
BAMT, 52 of the 380 persons to whom it was administered were
unable to perform the test. They were signiﬁcantly older (median
55.5y vs. 37.5y, Wilcoxon’s x2 = 42.7, P < 0.0001) with signiﬁcant-
ly less schooling (17.1% had more than 4y of school compared to
50.9%, Likelihood ratio x2 = 22.2, P < 0.0001). Their levels of B-Hg,
P-Se and B-Pb were similar to the others. We did not insist when
older people felt that they could not do the test. For the Santa Ana
and Dynamometer tests, only a few persons with arm or hand
injuries were unable to perform the tests. Performance on the
Grooved Pegboard test is dependent on near visual acuity and, in
order to ensure that participants had adequate vision to perform
the test, persons with near visual acuity greater or equal to 20/40
for at least one eye or with ophthalmic abnormalities or visual
diseases were not included in the analyses. A total of 199 persons
were thus excluded, and the persons included were signiﬁcantly
younger (median 28.0y vs. 49.5y, Wilcoxon’s x2 = 173.8,
P < 0.0001) and tended to present lower B-Hg levels (median
38.4 vs. 43.8 mg/L, x2 = 3.4, P = 0.07).
Results of simple and multiple regression analyses between the
different Se biomarkers and neurofunctional test outcomes are
presented in Table 3. P-Se levels were positively correlated with
performance on the BAMT test, and this association remained
signiﬁcant when controlling for age, gender, education, smoking
and alcohol consumption, village location and tester (Model 1).
When B-Hg was included in the model, the b estimate increased by
37% and by 30% for B-Se and P-Se respectively (Model 2). In all of
these models, B-Hg was negatively associated with performance
on the BAMT (P < 0.01). B-Pb levels were not related to theTable 3
Results of simple correlation, simple regression and multiple regression models
between Se biomarkers and motor tests outcomes.
Outcomes Log-Se biomarkers, mg/L
B-Se P-Se H-Se U-Se
BAMT, number
r Pearson 0.08 0.12* 0.01 0.09
b crude 4.6 7.7* 1.0 2.9
(95% CI) (1.9/11.2) (0.8/14.6) (6.8/8.8) (1.1/6.9)
Model 1 ba 7.6* 9.6** 5.3 2.7
(95% CI) (1.5/13.8) (3.3/15.9) (2.2/12.8) (1.0/6.4)
R2 0.26 0.27 0.25 0.29
Model 2 bb 10.4* 12.5** 6.3y 2.6
(95% CI) (4.1/16.7) (6.0/18.9) (0.3/15.0) (1.0/6.2)
R2 0.29 0.29 0.26 0.31
Model 3 bc 7.8* 9.9* 5.4 2.7
(95% CI) (1.6/14.0) (3.5/16.3) (2.2/12.9) (0.9/6.4)
R2 0.26 0.27 0.25 0.29
Model 4 bd 10.3* 12.3** 7.2y 2.6
(95% CI) (3.9/16.6) (5.8/18.8) (0.4/14.8) (1.0/6.2)
R2 0.29 0.30 0.26 0.31
Santa Ana, dominant hand, number
r Pearson 0.13** 0.15** 0.13* 0.21**
b crude 2.8** 3.4** 3.1* 2.4**
(95% CI) (0.7/4.9) (1.2/5.6) (0.6/5.6) (1.1/3.6)
Model 1 b 1.9y 2.2* 1.5 1.4*
(95% CI) (0.4/3.8) (0.3/4.2) (0.5/3.8) (0.2/2.6)
R2 0.32 0.32 0.32 0.32
Model 2 b 2.4* 2.8** 1.9 1.4*
(95% CI) (0.5/4.4) (0.8/4.8) (0.4/4.3) (0.2/2.6)
R2 0.33 0.33 0.32 0.33
Model 3 b 1.9y 2.3* 1.6 1.4*
(95% CI) (0.001/3.9) (0.3/4.2) (0.7/3.9) (0.2/2.6)
R2 0.32 0.32 0.32 0.32
Model 4 b 2.4* 2.8** 1.9 1.4*
(95% CI) (0.5/4.4) (0.8/4.8) (0.4/4.3) (0.2/2.6)
R2 0.33 0.33 0.32 0.33
(95% CI) (0.5/6.0) (0.9/6.0) (3.5/5.9) (2.3/0.6)
Model 3 b 1.8 1.5 0.6 0.1
(95% CI) (1.4/5.0) (1.8/4.7) (4.1/5.2) (2.3/0.6)
Model 4 b 2.6 2.2 1.2 0.2
(95% CI) (0.7/5.8) (1.1/5.5) (3.5/6.0) (2.3/0.6)
Grooved pegboard, non dominant hand, sec
r Pearson 0.05 0.01 0.03 0.06
b crude 2.0 0.5 1.5 1.2
(95% CI) (3.6/7.7) (5.6/6.5) (5.3/8.3) (2.1/4.5)
Model 1 b 1.9 3.0 2.3 1.1
(95% CI) (7.3/3.6) (8.7/2.6) (9.0/4.3) (3.6/2.3)
Model 2 b 3.2 4.3 3.7 1.4
(95% CI) (8.9/2.5) (10.1/1.6) (10.5/3.2) (4.9/2.1)
Model 3 b 2.2 3.4 2.7 1.1
(95% CI) (7.7/3.3) (9.2/2.3) (9.4/4.0) (4.7/2.4)
Model 4 b 3.2 4.3 3.7 -1.4
(95% CI) (8.9/2.5) (10.2/1.5) (10.6/3.2) (4.9/2.2)
Grooved pegboard, non dominant hand, sec
r Pearson 0.08 0.07 0.02 0.07
b crude 3.3 3.2 1.2 1.6
(95% CI) (9.8/3.1) (10.1/3.7) (9.0/6.7) (2.2/5.4)
Model 1 b 8.4* 8.2* 6.4 2.8
(95% CI) (14.8/1.9) (14.9/1.5) (14.4/1.6) (7.0/1.3)
R2 0.22 0.22 0.20 0.24
Model 2 b 10.0** 9.6** 8.0y 3.0
(95% CI) (16.8/3.3) (16.5/2.6) (16.3/0.3) (7.2/1.1)
R2 0.23 0.23 0.21 0.25
Model 3 b 9.2** 8.2* 7.3y 2.9
(95% CI) (15.7/2.8) (15.9/2.4) (15.3/0.7) (7.1/1.3)
R2 0.24 0.23 0.21 0.25
Model 4 b 10.1** 9.8** 8.1* 3.0
(95% CI) (16.8/3.5) (16.7/2.9) (16.4/0.1) (7.3/1.1)
R2 0.24 0.24 0.22 0.25
a Model 1 was controlled for age, gender, education, smoking and alcohol
consumption, village location and tester (when appropriate).
b Model 2 corresponds to model 1 also controlled for log BHg.
c Model 3 corresponds to model 1 also controlled for log BPb.
d Model 4 corresponds to model 1 also controlled for log BHg and log BPb.
* P < 0.05.
** P < 0.01.
y P < 0.10.
Fig. 3. Plots of the regression models with P-Se biomarker (Model 2) for: (a) the BAMT, (b) the Santa Ana Test (dominant hand), (c) the Dynamometer Test (dominant hand),
and (d) the Grooved Pegboard Test (non-dominant hand).
Table 4
Results of multiple regression models between P–Se biomarker and motor tests
outcomes stratiﬁed at B-Hg median level.
Outcomesa Log P–Se b (95% CI)
B-Hg < 43 mg/L B-Hg  43 mg/L
BAMT, number 7.3 (1.5/16.1) 18.8 (8.8/28.8)**
Santa Ana, number
Dominant hand 1.9 (0.8/4.6) 4.0 (1.0/7.0)**
Non dominant hand 0.9 (3.4/1.7) 2.6 (0.03/5.3)y
Dynamometer, kg
Dominant hand 1.9 (2.6/6.4) 4.4 (0.3/9.1)y
Non dominant hand 0.2 (4.7/4.3) 4.8 (0.1/9.8)y
Grooved pegboard, sec
Dominant hand 4.2 (10.7/2.3) 4.6 (16.3/7.1)
Non dominant hand 6.4 (14.9/2.0) 15.8 (28.1/3.5)*
a Models controlled for age, gender, education, smoking and alcohol consump-
tion, village location, tester (when appropriate), and log B-Hg.
* P < 0.05.
** P < 0.01.
y P < 0.10
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in these models (< 10%).
For the Santa Ana and Dynamometer tests, better performances
were associated with increasing Se status for the dominant hand.
In the multiple regression models, P-Se was the biomarker most
strongly associated to these two outcomes, particularly when B-Hg
was included in the models (P-Se estimates for the dominant hand
increased by 27% for the Santa Ana and by 34% for the
Dynamometer) (Model 2). This was not the case when B-Pb was
included into the models 3, where P-Se estimates changed less
than 10%. For both tests, B-Hg was signiﬁcantly related to the
outcome (P < 0.05), while B-Pb was not (P  0.05).
For the Grooved Pegboard test, better performance was
signiﬁcantly associated with the Se levels for the non-dominant
hand. The b estimates for B-Se and P-Se status increased by 19%
and 17% in the multiple regression models controlled for B-Hg
(Models 2), but changed less than 10% when B-Pb levels were
included (Model 3). In these models, B-Hg and B-Pb levels were not
related to the outcome for this test (P  0.05). It should be noted
that because of the exclusion criteria for poor near visual acuity
and for ocular and visual diseases, this group was younger than the
others (median age: 28y), with lower B-Hg (median: 38.0 mg/L); all
biomarkers of Se, and B-Pb were similar.
In all of the models described in Table 3, when persons
presenting high Se status (>1000 mg/L of B-Se) were excluded, the
regression estimates for Se biomarkers remained similar. Plots of
the regression models with P-Se biomarker (Model 2) with BAMT,
and performance on the Santa Ana Test (dominant hand),Dynamometer Test (dominant hand) and Grooved Pegboard Test
(non-dominant hand) are shown in Fig. 3. The interaction terms
between Se biomarkers and B-Hg, as well as between Se
biomarkers and B-Pb were tested in all models, and found not
to be statistically signiﬁcant (P > 0.05).
Since B-Hg concentrations inﬂuenced the associations between
Se biomarkers and motor outcomes (Models 2), we stratiﬁed these
regression models for P-Se biomarker at median B-Hg levels
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the outcomes only when B-Hg was high, although in some cases it
was only a trend.
4. Discussion
This is the ﬁrst human study to report improved motor
functions in association with Se status in the upper-normal range
(mean P-Se concentrations: 163  104 mg/L, from 53 to 913 mg/L).
Beck et al. (2007) observed positive associations between P-Se and
grip strength in elderly women in the US, but Se status was
considerably lower than the present study, with mean serum Se
concentrations at 118  18 mg/L. P-Se was also positively associated
with grip strength, motor speed and coordination in an elderly
population in Italy, where mean P-Se concentrations were lower still:
75  12 mg/L (Lauretani et al., 2007; Shahar et al., 2010).
Given the elevated Se status in some individuals of the
population examined here, we had anticipated adverse effects of
Se on motor outcomes. In a naturally rich-Se area of China, B-Se
status above 1000 mg/L was associated with hair and nail loss, skin
lesions, garlic breath as well as gastro-intestinal disorders (Yang
et al., 1983). In a particularly heavily affected Chinese village,
where B-Se levels ranged from 1300 to 7500 mg/L, polyneuropathy
and paraesthesia were reported. On the contrary, in this Amazonian
population where B-Se ranged from 103 to 1500 mg/L, motor
performance improved with Se status.
Several factors may account for the differences between the
present study and the Chinese studies. First, in the present study
population, Se intake is mostly from diet (Lemire et al., 2010a),
which probably contains a mixture of Se organic forms (Whanger,
2002). In China, persons not only had high dietary intake but were
also heavily exposed to Se inorganic fumes (Liu et al., 2007; Yang
et al., 1983) which may be more toxic than the organic forms
(Rayman et al., 2008).
A second explanation regarding the absence of Se toxicity in this
study population is that Se-rich food such as Brazil nuts has always
been part of the Amazonian diet. It is possible that through
homeostatic adjustment of this essential element, persons
chronically exposed to Se may be able to adapt to higher Se status
(ATSDR, 2003; WHO, 1986), and may even develop mechanisms to
take advantage of such high Se intake (Mattson, 2008).
Third, the population in the present study has high concurrent
exposure to Hg, and higher levels of dietary Se may be required to
offset Hg-induced toxic effects, Hg-mediated oxidative stress and/
or to maintain optimal Se antioxidant enzymes (Fordyce, 2005;
Khan and Wang, 2009; Ralston and Raymond, 2010; Watanabe
et al., 1999a,b). Indeed, the motor functions assessed here have
been shown to be sensitive to Hg exposure (Dolbec et al., 2000;
Lebel et al., 1996, 1998; Lucchini et al., 2003). In the present study,
higher Se status was associated to improved performance on these
same functions, which require complex coordinated arm, hand and
ﬁnger movements, as well as strength. The association between Se
and neuromotor outcomes was consistently stronger when
adjusting for current exposure to Hg, but we do not have a
measure of life-long or in utero exposure to Hg.
Interestingly, when stratifying for B-Hg exposure, the associa-
tions between P-Se and motor performances were signiﬁcant only
when B-Hg was high. These results are consistent with our
previous ﬁndings on age-related cataracts, where we observed an
inverse association between P-Se and age-related cataracts when
B-Hg was high, suggesting that a high dietary Se intake may play a
role in offsetting some deleterious effects of elevated Hg (Lemire
et al., 2010b). We cannot answer the question as to whether the
beneﬁcial effects of Se on motor functions would be observed if this
population was not highly exposed to Hg. The stratiﬁed analyses
should be interpreted with caution since biomarkers of Se and Hgwere highly correlated, even though, in this region, the dietary
sources were not the same. The primary source of Hg was ﬁsh
consumption, while Brazil nuts constituted the primary source of
Se (Lemire et al., 2010a). Furthermore, sample size was low in some
analysis (i.e. Grooved Pegboard). Future studies should address this
issue with a larger sample size and in populations with lower Se
status and/or Hg exposure.
Animal studies have suggested that speciﬁc selenoproteins
such as selenoprotein P (SelP) may protect against Hg toxicity by
binding to Hg and reducing its availability for target proteins and
organs (Yoneda and Suzuki, 1997). Conversely, some authors have
suggested that selenoproteins may be key targets of Hg toxicity; Hg
very high afﬁnity for selenol groups in the active site of
selenoproteins would results in Hg-binding and compromising
selenoproteins enzymatic functions (Carvalho et al., 2008; Ganther
and Sunde, 2007; Ralston and Raymond, 2010; Seppa¨nen et al.,
2004). Hg might then cause functional Se deﬁciency, which could
be one of the root causes of Hg toxic effects in the brain (Ganther
and Sunde, 2007; Khan and Wang, 2009; Ralston and Raymond,
2010). Indeed, high Se intake has been shown to restore
selenoprotein activities and alleviate some of the toxic effects of
Hg in the foetus and brain of animal models (Folven et al., 2009;
Ganther and Sunde, 2007; Watanabe et al., 1999a,b). Kaur et al.
(2009) showed that organic Se (selenomethionine) can contribute
to mitigating Hg-induced oxidative damage in neural cell lines.
However, other studies have observed little inﬂuence of inorganic
Se diet on Hg developmental toxicity (Newland et al., 2008). These
discrepancies among experimental studies may be partly due to
the chemical forms and route of exposure of both Se and Hg in
experimental settings, which might differ from naturally occurring
conditions in human populations.
Based on the hypothesis that high Se intake would restore
selenoprotein activity inactivated by Hg-binding, some authors
have suggested that, when Se is in molar excess to Hg, Se would
prevent harmful effects of Hg exposure (Ralston and Raymond,
2010). This also implies that, at high Se intake, more Hg could be
tolerated in the brain without related-toxic effects. However, in the
cat brain, Ganther and Sunde (2007) observed that, contrary to the
liver, not all Hg is complexed to Se. These authors therefore suggest
that the relationship between Hg and Se may be more complex
than a direct molecular interaction, and that Se does not
necessarily offset all toxic effects of Hg in the brain and during
life-time exposure. Indeed, Heath et al. (2010) mentioned that the
most important inﬂuence on Hg neurotoxicity in aging rats was the
dose of MeHg rather than dietary Se co-administration. In the
present study population, where we observed deleterious effects of
Hg, the median B-Se to B-Hg molar ratio was 15.8, and ranged from
1.7 to 137. This suggests another rationale than 1:1 Se to Hg molar
ratio for the mechanistic of Se and Hg opposing effects in human
populations.
Other studies have examined effects of high B-Se in populations
with high B-Hg. In Inuit preschool children, where Se status is
higher than in the Amazon (mean B-Se: 411  387 mg/L, mean cord
blood Se: 347  166 mg/L) and derived mostly from marine mammals
and ﬁsh diet (Blanchet et al., 2000), neuromotor functions have been
shown to be inversely related to current B-Pb levels; however, no
association with prenatal or current B-Hg and B-Se was observed
(Despre´s et al., 2005). In this same cohort, Saint-Amour et al. (2006)
reported opposing associations of current B-Hg and B-Se levels with
visual evoked potentials (VEP), but the interpretation of the results
was unclear since Hg was associated with decreased latency, and Se
with delayed latency. In the follow-up study at 11 years of age,
prenatal Hg exposure was associated to an increased amplitude and
latency of the N1 component of event-related potentials (ERP), and
the standardized regression coefﬁcient for prenatal Hg and the N1
latency relation was stronger by 45% when adjusting for current B-Se
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2010).
In the Faroe Islands, where Se status is high but lower than
Nunavik (mean cord blood Se: 103  14 mg/L) and likewise comes
primarily from marine diet, cord blood Se did not modify the adverse
association between cord blood Hg and neurological deﬁcits in
neonates (Steuerwald et al., 2000) nor the association between cord
blood Hg and neurobehavioral changes in children at 7 years old (Choi
et al., 2008a). However, these studies did not provide information on
Se associations with the outcomes.
In the present study, P-Se biomarker showed the most
consistent and strongest associations to motor outcomes. There
is increasing evidence showing an important role of SelP for Se
supply to the brain and proper antioxidant functions in neurons
(Burk and Hill, 2009; Reeves and Hoffmann, 2009; Zhang et al.,
2008). SelP also happens to be the most important selenoprotein in
plasma (40–50% of total Se in plasma) (Schomburg et al., 2003). P-
Se may be the most biologically active fraction of Se in blood in
comparison to other blood constituents, hair and urine biomarkers.
Higher P-Se, and not B-Se concentrations, has also been associated
to a lower prevalence of age-related cataracts in this population
(Lemire et al., 2010b). The present ﬁndings suggest that P-Se or
plasma selenoproteins may be more sensitive Se biomarkers than
B-Se to detect and evaluate the relations between Se status and
health outcomes.
Several animal studies show important roles of selenoproteins
on brain and muscle functions in experimental conditions exempt
of Hg exposure. Many regions of the mouse brain are exceptionally
rich in selenoprotein gene expressions, suggesting that neurons are
a key functional site for Se (Zhang et al., 2008). Selenoproteins may
help mitigate neurodegeneration primarily through redox regula-
tion (Zhang et al., 2010), while in the muscle they may contribute
to the regulation of oxidative stress and calcium homeostasis
(Lescure et al., 2009). Biomolecules such as lipids, proteins and
DNA of both nervous and muscular systems are highly vulnerable
to oxidative stress (Schweizer et al., 2004; Carmeli et al., 2002). The
ﬁndings of the present study support the notion that Se
physiological functions may not be restricted to skeletal muscles,
but more likely act globally on several systems.
There is growing evidence suggesting that when considering
the effects of beneﬁcial nutrients in food, adverse effects of Hg on
neurologic and cardiovascular systems become more apparent
(Boucher et al., 2010; Choi et al., 2008b; Rice, 2008; Valera et al.,
2009; Lemire et al., 2010b). Conversely, the present ﬁndings show
that when the negative effects of Hg exposure are considered, we
may better estimate the beneﬁts of Se on the same neuromotor
outcome. This was the case even when Hg did not show a
signiﬁcant negative association with the outcome. Since the
relationships between Se biomarkers and the outcomes showed
greater increases with Hg exposure than with Pb exposure, it is
possible that the underlying counteracting mechanisms of Se on
Hg toxicity are more widespread in the brain or the muscles than
for Pb. Without adjustments for Hg and Pb exposures, the Se effect
was present, although not always highly signiﬁcant.
These ﬁndings of the present study are not necessarily
applicable to populations with lower Hg exposure and/or Se
status, which is the case for people who do not rely heavily on ﬁsh
consumption or marine mammal. The communities studied here
have among highest reported Hg exposure in the world today
(Passos and Mergler, 2008), and Se status presents a wide range. In
comparison, results on adult population from the National Health
and Nutrition Survey (NHANES) 2003–2004 for the United States
show median B-Hg of 1.0 mg/L for those of 20 years and older, with
the 95th percentile at 5.4 mg/L, and mean serum Se of
136.7  18.9 mg/L (40 years and older) (Centers for Disease Control
and Prevention, 2009; Laclaustra et al., 2010). The evaluation ofoptimal Se intake in human populations depends on several factors
including: the chemical speciation of Se which is most prominent in
the Se sources; the adequacy of other nutrients; the presence of
additional stressors and the body’s ability to make selenoproteins
(Rayman et al., 2008). The present results suggest that in populations
exposed to Hg, high dietary Se intake may be critical for adequate
brain and muscular functions and to offset deleterious effects of Hg.
However, we should remain vigilant on possible dietary Se beneﬁts
since there is currently no evidence that Se offsets all Hg-induced
toxic effects in ﬁsh-eating populations.
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